person · Reporting owner
McGuire Jonathan Will
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Flyte Aviation, Inc.RMED · Entity 8648 | Director · CEO & Secretary | November 20, 2022 | March 15, 2023 |
| Vivani Medical, Inc.EYES · Entity 6636 | Director | May 19, 2020 | May 20, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Flyte Aviation, Inc.
Report date November 20, 2022 · Filed March 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,083 |
Reported balance
After 2022-11-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-11-20 · Tax withholding · Disposed 84 · Balance 1,083 F1: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities. F2: Reflects shares as a result of a reverse stock split. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities.
F2: Reflects shares as a result of a reverse stock split.
Vivani Medical, Inc.
Report date May 19, 2020 · Filed May 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,469 |
Reported balance
After 2020-05-19 transaction · row 1
1 source rowRow 1 · 2020-05-19 · Disposition to issuer · Disposed 3,357 · Balance 20,469 F1: Shares were sold under a rescission offer made to certain ESPP purchasers by the Company. The average price paid for the shares was determined by the original purchase price plus interest until the closing date of the repurchase. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were sold under a rescission offer made to certain ESPP purchasers by the Company. The average price paid for the shares was determined by the original purchase price plus interest until the closing date of the repurchase.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 30, 2017 Filed Aug 31, 2017 21:17 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Disposition to issuerCommon Stock | 4,921 | $1.08 | $5,314.68 |
DisclosureSEC source: 0001615774-17-004890 · s107388_form4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,986 F2 · balance_after: 4,921 shares were sold to satisfy the tax withholding requirements on vesting of RSUs. Read SEC document |
| August 18, 2017 Filed Aug 31, 2017 21:17 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $0.97 | $11,518.75 |
DisclosureSEC source: 0001615774-17-004890 · s107388_form4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon quarterly vesting of Restricted Stock Units (RSUs). Read SEC document |
| May 19, 2017 Filed May 23, 2017 10:05 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001615774-17-002606 · s106170_form4.xml · derivative · entry 7 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,875 Underlying: Common Stock · 190,000 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. F5 · price: Not Applicable. F3 · derivative.exercise_date: Options and RSUs vest over a 4 year term, with 25% vesting on the Date Exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%. Read SEC document |
| May 19, 2017 Filed May 23, 2017 10:05 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Disposition to issuerCommon Stock | 4,562 | $1.15 | $5,245.84 |
DisclosureSEC source: 0001615774-17-002606 · s106170_form4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,111 F2 · balance_after: 4,562 shares were sold to satisfy the tax withholding requirements on vesting of RSUs. Read SEC document |
| May 18, 2017 Filed May 23, 2017 10:05 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $1.16 | $13,775.00 |
DisclosureSEC source: 0001615774-17-002606 · s106170_form4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon quarterly vesting of Restricted Stock Units (RSUs). Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:36 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantWarrant to Purchase Common Stock · Derivative | 6,794 | Not disclosed Strike: $1.47 | Not disclosed |
DisclosureSEC source: 0001615774-17-001101 · s105584_form4.xml · derivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,794 Underlying: Common Stock · 6,794 shares Expires 2022-03-14 F1 · shares: Common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocation numbers of units were distributed on March 14, 2017. F1 · price: Common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocation numbers of units were distributed on March 14, 2017. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:36 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 6,794 | $1.47 | $9,987.18 |
DisclosureSEC source: 0001615774-17-001101 · s105584_form4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,798 Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 17:48 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001615774-17-001042 · s105567_form4.xml · derivative · entry 6 McGuire Jonathan Will · CIK 0001345539 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,750 Underlying: Common Stock · 190,000 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. F5 · price: Not Applicable. F3 · derivative.exercise_date: Options and RSUs vest over a 4 year term, with 25% vesting on the date exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 17:48 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Disposition to issuerCommon Stock | 4,562 | $1.41 | $6,432.42 |
DisclosureSEC source: 0001615774-17-001042 · s105567_form4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,004 F2 · balance_after: 4,562 shares were sold to satisfy the tax withholding requirements on vesting of RSUs. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 17:48 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $1.44 | $17,100.00 |
DisclosureSEC source: 0001615774-17-001042 · s105567_form4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon quarterly vesting of Restricted Stock Units (RSUs). Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:10 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 571,330 | Not disclosed Strike: $1.97 | Not disclosed |
DisclosureSEC source: 0001615774-17-000052 · s105064_form4.xml · derivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,330 Underlying: Common Stock · 571,330 shares Expires 2027-01-03 F2 · shares: Options to purchase 571,330 shares of the Company's common stock were granted to Mr. McGuire under the Company's 2011 Equity Incentive Plan. F5 · price: Not Applicable. F3 · derivative.exercise_date: Options and RSU vest over a four year term of which one-fourth vests on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 01:40 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001615774-16-008556 · s104777_form4.xml · derivative · entry 5 McGuire Jonathan Will · CIK 0001345539 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,625 Underlying: Common Stock · 190,000 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. F5 · price: Not Applicable. F3 · derivative.exercise_date: Options and RSUs vest over a 4 year term, with 25% vesting on the date exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 01:40 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Disposition to issuerCommon Stock | 4,570 | $2.33 | $10,643.53 |
DisclosureSEC source: 0001615774-16-008556 · s104777_form4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,725 F2 · balance_after: 4,570 shares were sold to satisfy the tax withholding requirements on vesting of RSUs. Read SEC document |
| November 18, 2016 Filed Nov 23, 2016 01:40 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $2.35 | $27,906.25 |
DisclosureSEC source: 0001615774-16-008556 · s104777_form4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon quarterly vesting of Restricted Stock Units (RSUs). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.